BTG plc is an international specialist healthcare company. The Company is focused on three business areas: Specialty Pharmaceuticals, Interventional Medicine and Licensing & Biotechnology. Its focus within Specialty Pharmaceuticals is on antidote products that are used within hospitals. Its interventional medicine products are embolisation and drug-eluting beads used primarily to treat patients with liver tumors and Brachytherapy products used mainly for early-stage prostate cancer. Licensing & Biotechnology business area consists of licensed products and programmes and generates royalties for BTG. The Company�s subsidiaries include BTG International (Holdings) Ltd, Provensis Ltd, BTG International Ltd, BTG Employee Share Schemes Ltd and BTG Management Services Ltd.